MCID: PYL006
MIFTS: 47

Pyloric Stenosis

Categories: Gastrointestinal diseases

Aliases & Classifications for Pyloric Stenosis

MalaCards integrated aliases for Pyloric Stenosis:

Name: Pyloric Stenosis 12 29 55 6 44 15 17 72

Classifications:



External Ids:

Disease Ontology 12 DOID:12639
MeSH 44 D011707
NCIt 50 C34966
ICD10 33 K31.1
UMLS 72 C0034194

Summaries for Pyloric Stenosis

MalaCards based summary : Pyloric Stenosis is related to hypertrophic pyloric stenosis and pyloric stenosis, infantile hypertrophic, 1. An important gene associated with Pyloric Stenosis is MAP1B (Microtubule Associated Protein 1B), and among its related pathways/superpathways are Neuroscience and TRP channels. The drugs Azithromycin and Cimetropium have been mentioned in the context of this disorder. Affiliated tissues include pancreas, small intestine and liver, and related phenotypes are behavior/neurological and growth/size/body region

Wikipedia : 75 Pyloric stenosis is a narrowing of the opening from the stomach to the first part of the small intestine... more...

Related Diseases for Pyloric Stenosis

Diseases related to Pyloric Stenosis via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 290)
# Related Disease Score Top Affiliating Genes
1 hypertrophic pyloric stenosis 30.9 TRPC6 TRPC5 SST RET NOS1 NKX2-5
2 pyloric stenosis, infantile hypertrophic, 1 12.9
3 pyloric stenosis, infantile hypertrophic, 5 12.6
4 pyloric stenosis, infantile hypertrophic, 2 12.6
5 pyloric stenosis, infantile hypertrophic, 4 12.6
6 pyloric stenosis, infantile hypertrophic, 3 12.6
7 intellectual disability-hypotonia-brachycephaly-pyloric stenosis-cryptorchidism syndrome 12.4
8 acquired gastric outlet stenosis 12.2
9 duodenal atresia 11.7
10 congenital generalized lipodystrophy 11.5
11 epidermolysis bullosa junctionalis with pyloric atresia 11.4
12 myhre syndrome 11.4
13 gastritis 10.6
14 peptic ulcer disease 10.6
15 pylorospasm 10.5
16 gastrointestinal ulceration, recurrent, with dysfunctional platelets 10.5
17 duodenal ulcer 10.5
18 esophageal atresia 10.5
19 gastric ulcer 10.5
20 tracheoesophageal fistula with or without esophageal atresia 10.5
21 gastric cancer 10.5
22 muscle hypertrophy 10.5
23 gastroesophageal reflux 10.4
24 dyspepsia 10.4
25 gastroenteritis 10.4
26 eosinophilic gastroenteritis 10.4
27 intestinal volvulus 10.4
28 achalasia 10.4
29 eosinophilic enteropathy 10.4
30 bilirubin metabolic disorder 10.3
31 gastric dilatation 10.3
32 intestinal obstruction 10.3
33 crohn's disease 10.3
34 esophagitis 10.3
35 hypokalemia 10.3
36 tracheoesophageal fistula 10.3
37 sudden infant death syndrome 10.2
38 mycobacterium tuberculosis 1 10.2
39 inguinal hernia 10.2
40 microinvasive gastric cancer 10.2
41 pertussis 10.2
42 pneumatosis cystoides intestinalis 10.2
43 adenomyoma 10.2
44 kidney disease 10.2
45 47,xyy 10.2
46 gilbert syndrome 10.2
47 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 10.2
48 acute cystitis 10.2
49 epidermolysis bullosa 10.2
50 hypoglycemia 10.2

Graphical network of the top 20 diseases related to Pyloric Stenosis:



Diseases related to Pyloric Stenosis

Symptoms & Phenotypes for Pyloric Stenosis

MGI Mouse Phenotypes related to Pyloric Stenosis:

46
# Description MGI Source Accession Score Top Affiliating Genes
1 behavior/neurological MP:0005386 10.16 DMD MAP1B MBNL1 MTA3 NOS1 NTRK1
2 growth/size/body region MP:0005378 10.02 BARX1 DMD MAP1B MBNL1 NKX2-5 NOS1
3 mortality/aging MP:0010768 10.02 BARX1 DMD FOXF1 MAP1B MBNL1 NKX2-5
4 cardiovascular system MP:0005385 9.98 DMD FOXF1 MBNL1 NKX2-5 NOS1 RET
5 digestive/alimentary MP:0005381 9.95 BARX1 DMD FOXF1 NKX2-5 NOS1 RET
6 muscle MP:0005369 9.86 DMD FOXF1 MBNL1 NKX2-5 NOS1 NTRK1
7 nervous system MP:0003631 9.85 DMD MAP1B MBNL1 NKX2-5 NOS1 NTRK1
8 no phenotypic analysis MP:0003012 9.5 DMD NKX2-5 NOS1 NTRK1 RET SST
9 vision/eye MP:0005391 9.1 DMD MAP1B MBNL1 NOS1 NTRK1 TRPC6

Drugs & Therapeutics for Pyloric Stenosis

Drugs for Pyloric Stenosis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show all 50)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Azithromycin Approved Phase 4 83905-01-5 447043 55185
2
Cimetropium Experimental, Investigational Phase 4 150521-16-7
3 Parasympatholytics Phase 4
4 Cola Phase 4
5 Pharmaceutical Solutions Phase 4
6 Anticonvulsants Phase 4
7 Bromides Phase 4
8
Midazolam Approved, Illicit Phase 3 59467-70-8 4192
9 Anesthetics Phase 3
10
Ethanol Approved Phase 2 64-17-5 702
11
Mecamylamine Approved, Investigational Phase 2 60-40-2 4032
12 Peripheral Nervous System Agents Phase 2
13 Central Nervous System Depressants Phase 2
14 Cholinergic Agents Phase 2
15 Neurotransmitter Agents Phase 2
16 Cholinergic Antagonists Phase 2
17 Autonomic Agents Phase 2
18 Antihypertensive Agents Phase 2
19 Anti-Infective Agents, Local Phase 2
20 Anti-Infective Agents Phase 2
21 Antidepressive Agents Phase 2
22
Serotonin Investigational, Nutraceutical Phase 2 50-67-9 5202
23
Fentanyl Approved, Illicit, Investigational, Vet_approved 437-38-7 3345
24
Sevoflurane Approved, Vet_approved 28523-86-6 5206
25
Propofol Approved, Investigational, Vet_approved 2078-54-8 4943
26
Epinephrine Approved, Vet_approved 51-43-4 5816
27
Racepinephrine Approved 329-65-7 838
28
Rocuronium Approved 119302-91-9, 143558-00-3 441290
29
Bupivacaine Approved, Investigational 2180-92-9, 38396-39-3 2474
30
Acetaminophen Approved 103-90-2 1983
31
Methylene blue Approved, Investigational 61-73-4
32
Sodium citrate Approved, Investigational 68-04-2
33
Esomeprazole Approved, Investigational 119141-88-7, 161796-78-7, 161973-10-0 9568614 4594
34
Citric acid Approved, Nutraceutical, Vet_approved 77-92-9 311
35
Calcium Approved, Nutraceutical 7440-70-2 271
36 Mosapride Investigational 112885-41-3
37 Epinephryl borate
38 Analgesics, Non-Narcotic
39 Analgesics
40 Antipyretics
41 Gastrointestinal Agents
42 Antacids
43 Serotonin Receptor Agonists
44 Citrate
45 Chelating Agents
46 Serotonin Agents
47 Proton Pump Inhibitors
48 Anticoagulants
49 Calcium, Dietary
50 Anti-Ulcer Agents

Interventional clinical trials:

(show all 33)
# Name Status NCT ID Phase Drugs
1 Phase IV Study of Double Bare Self-expandable Metallic Stent for Malignant Gastric Outlet Obstruction Unknown status NCT02156505 Phase 4
2 Usefulness Of Flospan As A Premedication For Colonoscopy : A Randomized Double Blind Controlled Trial Unknown status NCT01842932 Phase 4 Phloroglucin;Cimetropium bromide;Placebo
3 Outcomes of Stapled Trans-Anal Rectal Resection (STARR) vs. Biofeedback in the Treatment of Outlet Obstruction Associated With Rectal Intussusception and Rectocele: A Multi-center Randomized Controlled Trial Completed NCT00556283 Phase 4
4 Neonates and Azithromycin, an Innovation in the Treatment of Children in Burkina Faso Recruiting NCT03682653 Phase 4 Azithromycin;Placebo
5 Laparoscopic Versus Open Pyloromyotomy for Infants With Idiopathic Hypertrophic Pyloric Stenosis Completed NCT00195949 Phase 3
6 Comparison of Efficacy of Covered Versus Uncovered Self-expandable Metallic Stents for Treatment of Malignant Gastric Outlet Obstruction: a Prospective, Randomized Study Completed NCT01646476 Phase 3
7 Partially Covered Versus Uncovered Pyloro-duodenal Stents for Unresectable Malignant Gastric Outlet Obstruction. A Double Blinded Randomised Controlled Trial. Recruiting NCT03223831 Phase 3
8 EUS - Guided Balloon-occluded Gastrojejunostomy Bypass (EPASS) for Unresectable Malignant Gastric Outlet Obstruction. Recruiting NCT03223480 Phase 2, Phase 3
9 Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis and Death: a Phase III Double-blind Randomized Clinical Trial Recruiting NCT03199547 Phase 3 Azithromycin;Placebo Oral Tablet
10 EUS-guided Balloon-occluded Gastrojejunostomy Bypass (EPASS) Versus Uncovered Duodenal Stent for Unresectable Malignant Gastric Outlet Obstruction. Not yet recruiting NCT03823690 Phase 3
11 Treatment With Mecamylamine in Smoking and Non-smoking Alcohol Dependent Patients Completed NCT00342563 Phase 2 mecamylamine;Placebo
12 A Double-Blind,Randomized,Placebo-Controlled Trial of Mecamylamine Hydrochloride for the Treatment of SSRI-Refractory Major Depressive Disorder. Completed NCT00319319 Phase 2 Mecamylamine hydrochloride (Inversine)
13 Open vs Laparoscopic Pyloromyotomy for Pyloric Stenosis Unknown status NCT00144924
14 The Effect of Hypertrophic Pyloric Stenosis (HPS) on Sodium Intake in Childhood Unknown status NCT01159509
15 Post-operative Outcomes in the Pyloromyotomy Procedure Under Spinal Anesthesia: A Retrospective Study in 100 Cases Unknown status NCT02879292
16 The Usefulness of Self-expandable Metal Stents(SEMS) for Malignant Gastric Outlet Obstruction: a Prospective Study Using New Designed Stents Unknown status NCT02440724
17 Multinational Study on Endoscopic Management of Distal Malignant Biliary Obstruction Combined With Gastric Outlet Obstruction Unknown status NCT02376907
18 A Retrospective Comparative Study, Post Operative Outcomes of Pyloromyotomy Procedure Under Spinal Anesthesia Compared to General Anesthesia Unknown status NCT03095144
19 Post-Operative Impact of Nasogastric Tubes on Rates of Emesis in Infants Diagnosed With Pyloric Stenosis: A Prospective, Randomized Controlled Pilot Trial Completed NCT01139853 Early Phase 1
20 Institutional Audit of the Use of Intravenous Acetaminophen in Infants Undergoing Pyloromyotomy Completed NCT02359305 Acetaminophen;Acetaminophen
21 Frequency of Formula Change Prior to the Accurate Diagnosis of Pyloric Stenosis Completed NCT00409734
22 A Newly Designed Conformable Uncovered Versus Covered Self-expandable Metallic Stent for Palliation of Malignant Gastric Outlet Obstruction: a Prospective, Randomized Multicenter Study Completed NCT01839292
23 Treatment of Duodenal or Gastric Outlet Obstruction and Duodenal Strictures Caused by Malignant Neoplasms With the EVOLUTION® Duodenal Stent Completed NCT00991614
24 Changes in Cerebral Oxygenation During Laparoscopic Pyloromyotomy Completed NCT03650842
25 Prospective Randomized Trial Evaluating the Feeding Regimen After Pyloromyotomy. Completed NCT01509417
26 A Multicenter Randomized Controlled Trial of Malignant Gastric Outlet Obstruction: Tailored Partially Covered Stents (Placed Fluoroscopically) Versus Standard Uncovered Stents (Placed Endoscopically) Completed NCT02299258
27 A Prospective Randomized Trial to Assess Optimal Postoperative Feeding Regiments Following Pyloromyotomy Completed NCT02415049
28 Evaluation of the Efficacy of Duodenal Prostheses Not Covered Over 6 Years Recruiting NCT03463668
29 Cooperative Group for Clinical Research in G-POEM (POP), Jiangsu, China Recruiting NCT03040817 Esomeprazole + Mosapride
30 EUS-guided Gastroenterostomy Versus Enteral Stenting for Palliation of Malignant Gastric Outlet Obstruction: A Randomized Clinical Trial Recruiting NCT03259763
31 Natural History of Infants With Patent Processus Vaginalis Recruiting NCT03042858
32 Conventional Direct Laryngoscopy Vs. Video Laryngoscopy With The C-MAC For Pyloromyotomy Enrolling by invitation NCT02775214
33 Endoscopic Gastroenteric Anastomosis Formed by Magnetic Compression and Stent Placement for Palliation of Malignant Gastric Outlet Obstruction Terminated NCT00487552

Search NIH Clinical Center for Pyloric Stenosis

Cochrane evidence based reviews: pyloric stenosis

Genetic Tests for Pyloric Stenosis

Genetic tests related to Pyloric Stenosis:

# Genetic test Affiliating Genes
1 Pyloric Stenosis 29

Anatomical Context for Pyloric Stenosis

MalaCards organs/tissues related to Pyloric Stenosis:

41
Pancreas, Small Intestine, Liver, Testes, Heart, Colon, Breast

Publications for Pyloric Stenosis

Articles related to Pyloric Stenosis:

(show top 50) (show all 3042)
# Title Authors PMID Year
1
No association between a promoter NOS1 polymorphism (rs41279104) and Infantile Hypertrophic Pyloric Stenosis. 9 38
19851341 2009
2
Nonfatal congenital alveolar dysplasia due to abnormalities of NO synthase isoforms. 9 38
17590189 2007
3
Pyloric stenosis in a newborn baby with polycystic kidneys. 9 38
17262047 2007
4
Low plasma nitrite in infantile hypertrophic pyloric stenosis patients. 9 38
16758311 2006
5
[Pyloric stenosis and neuronal nitric oxide synthase]. 9 38
15361336 2004
6
Single-nucleotide promoter polymorphism alters transcription of neuronal nitric oxide synthase exon 1c in infantile hypertrophic pyloric stenosis. 9 38
14757827 2004
7
Pathophysiological significance of neuronal nitric oxide synthase in the gastrointestinal tract. 9 38
12768383 2003
8
Gastrin, somatostatin and infantile hypertrophic pyloric stenosis. 9 38
11529535 2001
9
Nitric oxide synthase is absent in only a subset of cases of pyloric stenosis. 9 38
11283889 2001
10
Distinct expression of splice variants of neuronal nitric oxide synthase in the human gastrointestinal tract. 9 38
10784584 2000
11
Endogenous nitric oxide synthesis: biological functions and pathophysiology. 9 38
10630682 1999
12
Neuronal nitric oxide synthase, nNOS, is not linked to infantile hypertrophic pyloric stenosis in three families. 9 38
9660065 1998
13
Altered messenger RNA expression of the neuronal nitric oxide synthase gene in infantile hypertrophic pyloric stenosis. 9 38
9354728 1997
14
Gastric somatostatin content and binding in children with hypertrophic pyloric stenosis: a long-term follow-up study. 9 38
8786484 1995
15
Nitric oxide in the peripheral nervous system. 9 38
7546628 1995
16
Immunochemical characterization of neural cell adhesion molecule (NCAM), nitric oxide synthase, and neurofilament protein expression in pyloric muscle of patients with pyloric stenosis. 9 38
7541835 1995
17
Serum gastrin level and gastric somatostatin content and binding in long-term pyloromyotomized children. 9 38
7913200 1994
18
Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis. 9 38
1378938 1992
19
Differences in Outcomes Based on Sex for Pediatric Patients Undergoing Pyloromyotomy. 38
31421364 2019
20
The Association Between Opioid Use and Outcomes in Infants Undergoing Pyloromyotomy. 38
31409555 2019
21
Prevalence of selected birth defects by maternal nativity status, United States, 1999-2007. 38
30920179 2019
22
Gastrointestinal: Natural progression of early gastric cancer causing pyloric stenosis. 38
31273829 2019
23
Surgical treatment of pyloric stenosis caused by glyphosate poisoning: A case report. 38
31348300 2019
24
The Impact of Sociodemographic and Hospital Factors on Length of Stay Before and After Pyloromyotomy. 38
30782541 2019
25
Focal pyloric hypertrophy in adults: a diagnostic pitfall-a case report and review of the literature. 38
31346979 2019
26
Spinal anesthesia compared with general anesthesia for neonates with hypertrophic pyloric stenosis. A retrospective study. 38
31322795 2019
27
Gastric ectopic pyloric opening: an unusual case. 38
31264000 2019
28
Gastric Peroral Endoscopic Myotomy for Treatment of Congenital Pyloric Stenosis-First Clinical Experience. 38
31017541 2019
29
The spectrum of self inflicted injuries managed at a major trauma centre in South Africa. 38
31342690 2019
30
Infantile hypertrophic pyloric stenosis: profile, management and outcome of patients admitted to a tertiary hospital in Bloemfontein, South Africa. 38
31342689 2019
31
Co-occurrence of infantile hypertrophic pyloric stenosis and congenital heart defects: a nationwide cohort study. 38
30862960 2019
32
Neuromuscular Blocking Agents and Rapid Sequence Induction for Laparoscopic Pyloromyotomy: Impact on Time to Extubation and Perioperative Complications. 38
31242510 2019
33
Venous Physiology Predicts Dehydration in the Pediatric Population. 38
30776742 2019
34
Palliation of Malignant Pyloric Stenosis Using a Lumen-Apposing Metal Stent. 38
29609066 2019
35
Caterpillar Sign in an Infant with Hypertrophic Pyloric Stenosis. 38
30723016 2019
36
Milk vomiting or regurgitation in the first 3 months of life: Something old-something new. 38
31160085 2019
37
The incidence of infantile hypertrophic pyloric stenosis and its association with folic acid supplementation during pregnancy: A nested case-control study. 38
29884554 2019
38
Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. 38
30470884 2019
39
Developmental outcome at 3 years of age of infants following surgery for infantile hypertrophic pyloric stenosis. 38
30402682 2019
40
Congenital absence of lingual frenum in a non-syndromic patient: a case report. 38
30851733 2019
41
Minimally Invasive Supraumbilical Approach for Pyloromyotomy. 38
31237854 2019
42
Primary acquired gastric outlet obstruction in children: A retrospective single center study. 38
30922687 2019
43
Efficacy of macrolides on gastric motility in extremely low birth weight infants. 38
30883365 2019
44
ACTG2-Associated Visceral Myopathy With Chronic Intestinal Pseudoobstruction, Intestinal Malrotation, Hypertrophic Pyloric Stenosis, Choledochal Cyst, and a Novel Missense Mutation. 38
30019982 2019
45
Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010. 38
30549250 2019
46
The association of prenatal and postnatal macrolide exposure with subsequent development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. 38
30717812 2019
47
The Application of Pyloric chisel in the Treatment of Hypertrophic Pyloric Stenosis by Single-Site Umbilical Laparoscopic Pyloromyotomy. 38
30289351 2019
48
An endoscopic method for semi-quantitatively measuring internal pyloric diameter in healthy cats: A prospective study of 24 cases. 38
30508705 2019
49
Our experience of laparoscopic pyloromyotomy with ultrasound-guided parameters. 38
29582798 2019
50
Genome-wide meta-analysis identifies BARX1 and EML4-MTA3 as new loci associated with infantile hypertrophic pyloric stenosis. 38
30281099 2019

Variations for Pyloric Stenosis

ClinVar genetic disease variations for Pyloric Stenosis:

6
# Gene Variation Type Significance SNP ID GRCh37 Pos GRCh38 Pos
1 MAP1B NM_005909.5(MAP1B): c.5368C> T (p.Arg1790Ter) single nucleotide variant Pathogenic 5:71494550-71494550 5:72198723-72198723
2 CHD7 NM_017780.4(CHD7): c.2867C> A (p.Ser956Ter) single nucleotide variant Likely pathogenic rs367557471 8:61734614-61734614 8:60822055-60822055
3 46;XY;t(2;13)(p25.2;q31.3)dn Translocation Uncertain significance

Expression for Pyloric Stenosis

Search GEO for disease gene expression data for Pyloric Stenosis.

Pathways for Pyloric Stenosis

Pathways related to Pyloric Stenosis according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.46 TRPC6 RET NTRK1 NOS1
2 10.55 TRPC6 TRPC5
3 10.23 NOS1 DMD

GO Terms for Pyloric Stenosis

Cellular components related to Pyloric Stenosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 dendrite GO:0030425 9.62 TRPC5 RET NTRK1 MAP1B
2 axon GO:0030424 9.56 RET NTRK1 MAP1B DMD
3 membrane raft GO:0045121 9.26 TRPC5 RET NOS1 DMD
4 cation channel complex GO:0034703 9.16 TRPC6 TRPC5
5 neuronal cell body GO:0043025 9.1 TRPC5 SST RET NTRK1 MAP1B DMD
6 cytoplasm GO:0005737 10.02 TRPC6 TRPC5 NTRK1 NOS1 NKX2-5 MTA3

Biological processes related to Pyloric Stenosis according to GeneCards Suite gene sharing:

(show all 17)
# Name GO ID Score Top Affiliating Genes
1 positive regulation of transcription, DNA-templated GO:0045893 9.86 RET NOS1 NKX2-5 FOXF1
2 positive regulation of cell proliferation GO:0008284 9.84 TRPC5 NKX2-5 MTA3 DMD
3 aging GO:0007568 9.65 TRPC6 NTRK1 DMD
4 regulation of cytosolic calcium ion concentration GO:0051480 9.57 TRPC6 TRPC5
5 regulation of cardiac conduction GO:1903779 9.55 NOS1 NKX2-5
6 nervous system development GO:0007399 9.55 TRPC5 RET NTRK1 MBNL1 MAP1B
7 positive regulation of neuron projection development GO:0010976 9.54 RET NTRK1 DMD
8 spleen development GO:0048536 9.52 NKX2-5 BARX1
9 positive regulation of axon extension GO:0045773 9.51 TRPC5 MAP1B
10 positive regulation of peptidyl-threonine phosphorylation GO:0010800 9.49 TRPC6 TRPC5
11 innervation GO:0060384 9.46 RET NTRK1
12 regulation of cardiac muscle contraction GO:0055117 9.43 NOS1 NKX2-5
13 regulation of ryanodine-sensitive calcium-release channel activity GO:0060314 9.4 NOS1 DMD
14 manganese ion transport GO:0006828 9.32 TRPC6 TRPC5
15 negative regulation of dendrite morphogenesis GO:0050774 9.26 TRPC6 TRPC5
16 neuron differentiation GO:0030182 9.26 TRPC6 TRPC5 RET DMD
17 positive regulation of neuron differentiation GO:0045666 8.92 TRPC6 TRPC5 NKX2-5 DMD

Molecular functions related to Pyloric Stenosis according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 DNA-binding transcription activator activity, RNA polymerase II-specific GO:0001228 9.5 NKX2-5 FOXF1 BARX1
2 actin binding GO:0003779 9.46 TRPC6 TRPC5 MAP1B DMD
3 clathrin binding GO:0030276 9.37 TRPC6 TRPC5
4 inositol 1,4,5 trisphosphate binding GO:0070679 9.26 TRPC6 TRPC5
5 store-operated calcium channel activity GO:0015279 8.96 TRPC6 TRPC5
6 actinin binding GO:0042805 8.62 TRPC6 TRPC5

Sources for Pyloric Stenosis

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....